Cold-stored cadaveric venous allograft for superior mesenteric/portal vein reconstruction during pancreatic surgery

HPB (Oxford). 2016 Jul;18(7):615-22. doi: 10.1016/j.hpb.2016.05.010. Epub 2016 Jun 20.

Abstract

Background: SMV/PV resection has become common practice in pancreatic surgery. The aim of this study was to evaluate the technical feasibility and surgical outcome of using cold-stored cadaveric venous allografts (AG) for superior mesenteric vein (SMV) and portal vein (PV) reconstruction during pancreatectomy.

Methods: Patients who underwent pancreatic resection with concomitant vascular resection and reconstruction with AG between January 2006 and December 2014 were identified from our institutional prospective database. Medical records and pre- and postoperative CT-images were reviewed.

Results: Forty-five patients underwent SMV/PV reconstruction with AG interposition (n = 37) or AG patch (n = 8). The median operative time and blood loss were 488 min (IQR: 450-551) and 900 ml (IQR: 600-2000), respectively. Major morbidity (Clavien ≥ III) occurred in 16 patients. Four patients were reoperated (thrombosis n = 2, graft kinking/low flow n = 2) and in-hospital mortality occurred in two patients. On last available CT scan, 3 patients had thrombosis, all of whom also had local recurrence. Estimated cumulative patency rate (reduction in SMV/PV luminal diameter <70% and no thrombosis) at 12 months was 52%.

Conclusion: Cold-stored cadaveric venous AG for SMV/PV reconstruction during pancreatic surgery is safe and associated with acceptable long-term patency.

Publication types

  • Evaluation Study

MeSH terms

  • Aged
  • Allografts
  • Blood Loss, Surgical
  • Cadaver
  • Cold Temperature* / adverse effects
  • Feasibility Studies
  • Female
  • Hospital Mortality
  • Humans
  • Iliac Vein / diagnostic imaging
  • Iliac Vein / transplantation*
  • Male
  • Mesenteric Veins / surgery*
  • Middle Aged
  • Operative Time
  • Organ Preservation / adverse effects
  • Organ Preservation / methods*
  • Organ Preservation / mortality
  • Pancreatectomy / adverse effects
  • Pancreatectomy / methods*
  • Pancreatectomy / mortality
  • Pancreaticoduodenectomy / adverse effects
  • Pancreaticoduodenectomy / methods*
  • Pancreaticoduodenectomy / mortality
  • Phlebography / methods
  • Portal Vein / surgery*
  • Reoperation
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Tissue Donors*
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Ultrasonography, Doppler
  • Vascular Patency